DEPTOR and ovarian cancer: However, DEPTOR was also reported to have an oncogenic role and found to be overexpressed in many cancers such as multiple myeloma, paclitaxel resistant ovarian cancer, hepatocellular carcinoma and thyroid cancer [3, 4, 6, 8].